Page 7,050«..1020..7,0497,0507,0517,052..7,0607,070..»

Kids' Concussion Symptoms Can Last a Year, Study Says

Posted: Published on March 6th, 2012

MONDAY, March 5 (HealthDay News) -- Some children who suffer a concussion will display continued difficulties, such as attention and memory problems, for many months, a new study finds. Concussions, also known as mild traumatic brain injury, are common in childhood, with more than 500,000 children and teens a year needing hospital treatment for these injuries, the researchers note. "The results of the study suggest that the majority of kids who sustain mild traumatic brain injuries actually do quite well and don't have to have persistent symptoms after their injury," said lead researcher Keith Owen Yeates, director of Behavioral Health Services at Nationwide Children's Hospital in Columbus, Ohio. "But, there is a small, but significant proportion of kids that do go on to have persistent symptoms after their injury, lasting as long as three to 12 months," he added. The extent and duration of the symptoms appear to be related to the severity of the injury, and can affect quality of life and school performance, he said. Kids shouldn't go back to play until their symptoms are gone, and the medical profession must fine-tune guidelines regarding permissible post-concussion activity, Yeates said. The report was published in the March 5 online … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Kids' Concussion Symptoms Can Last a Year, Study Says

Amantadine, Old Flu Drug, Speeds Brain Injury Recovery: Study

Posted: Published on March 6th, 2012

NEW YORK Researchers are reporting the first treatment to speed recovery from severe brain injuries caused by falls and car crashes: a cheap flu medicine whose side benefits were discovered by accident decades ago. Severely injured patients who were given amantadine got better faster than those who received a dummy medicine. After four weeks, more people in the flu drug group could give reliable yes-and-no answers, follow commands or use a spoon or hairbrush things that few of them could do at the start. Far fewer patients who got amantadine remained in a vegetative state, 17 percent versus 32 percent. "This drug moved the needle in terms of speeding patient recovery, and that's not been shown before," said neuropsychologist Joseph Giacino of Boston's Spaulding Rehabilitation Hospital, co-leader of the study. He added: "It really does provide hope for a population that is viewed in many places as hopeless." Many doctors began using amantadine for brain injuries years ago, but until now there's never been a big study to show that it works. The results of the federally funded study appear in Thursday's New England Journal of Medicine. A neurologist who wasn't involved in the research called it an important step. … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Amantadine, Old Flu Drug, Speeds Brain Injury Recovery: Study

Frequency, Severity and Cost of Brain Injuries Demand Increased Awareness

Posted: Published on March 6th, 2012

SACRAMENTO, Calif., March 5, 2012 /PRNewswire/ --A brain injury can happen to anyone, anytime, anywhere in the world. According to the Brain Injury Association of California,approximately 1.7 million Americans sustain a traumatic brain injury each year, and a brain injury occurs somewhere in the U.S. every 21 seconds. "Brain injuries are permanent and create devastating and life-altering conditions for those affected for the rest of their lives," states Elsa Quezada, Chair of the State Independent Living Council (SILC) and Executive Director of the Central Coast Center for Independent Living. "Considering the impact and cost of these types of injuries and that California has only seven traumatic brain injury centers, the role of independent living centers throughout the state is even more critical." Brain injuries result from various causes, including motor vehicle accidents, sports-related head injuries, strokes, aneurysms and the primary injury among seniors, slipping and falling. The cost to treat such injuries is confounding. According to the Centers for Disease Control and Prevention's (CDC) 2010 presentation, the "public health burden of traumatic brain injuries in the United States annually represents 52,000 deaths, 275,000 hospitalizations and 1,365,000 emergency room visits." "And the numbers are increasing with an estimated 20 percent of … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Frequency, Severity and Cost of Brain Injuries Demand Increased Awareness

Neiwand treatment to continue

Posted: Published on March 6th, 2012

Sentencing of Olympic cyclist Gary Neiwand for obscene exposure has been adjourned while he continues treatment. Neiwand, 45, exposed his genitals to two women in Melbourne last year. In December, he pleaded guilty in the Melbourne Magistrates Court to two counts of wilful and obscene exposure. Neiwand has been attending the Victorian Institute of Forensic Mental Health, known as Forensicare, for counselling and treatment before sentencing. On Monday, deputy chief magistrate Jelena Popovic said she had been told Neiwand was engaging in treatment in a "much more worthwhile fashion" and now had an understanding of what his victims had gone through. She said that in the past he had gone into "shutdown mode" during the sessions. Ms Popovic said Neiwand was now doing all the right things and the best option for the community was for his treatment to continue. She adjourned the case until September 5 while Neiwand's treatment is ongoing. Neiwand was driving in Elwood on January 24 when he pulled alongside a female cyclist who had stopped on the side of the road. He then wound down the front passenger window and asked the woman "can you finish this off" while holding his exposed genitals. See the … Continue reading →

Posted in MS Treatment | Comments Off on Neiwand treatment to continue

Treatment for a cancer that Ontario woman never had ‘led to profound brain damage’

Posted: Published on March 6th, 2012

Tom Blackwell Mar 4, 2012 10:41 PM ET | Last Updated: Mar 5, 2012 8:34 AM ET The prognosis for Jessie Kay was so grim after a mysterious seizure, her children just hoped doctors could buy the 66-year-old a little extra time. Cancer had taken root in Ms. Kays lungs, then spread to several locations in her brain, a radiologist at Torontos Princess Margaret Hospital concluded after analyzing an MRI scan. Oncologists at the prestigious cancer centre went to work, applying treatment called whole-brain radiation to the grandmother from Barrie, Ont. There was just one problem: When another specialist looked at an image of her brain soon after the treatment, he realized she actually had infectious abscesses, not cancerous tumours. The radiation had been for naught. It soon became apparent the woman had suffered profound brain damage, leaving her with the intelligence of a child, unable to care for herself. Last week, a judge gave the green light for her family to move ahead with a $6-million lawsuit against Princess Margaret and the doctors who treated her there in mid-2008. The unsettling allegations, yet to be proved in court, underline again the potentially dire consequences of errors by diagnostic specialists, … Continue reading →

Posted in MS Treatment | Comments Off on Treatment for a cancer that Ontario woman never had ‘led to profound brain damage’

Concert Pharmaceuticals and Fast Forward Announce Collaboration to Advance Novel Treatment for Spasticity and Pain in …

Posted: Published on March 6th, 2012

LEXINGTON, Mass. & NEW YORK--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. and Fast Forward, LLC, the National Multiple Sclerosis Societys subsidiary devoted to bridging the gap between research and drug development, today announced a new collaboration to fund the preclinical advancement of C-21191, a deuterium-modified subtype-selective GABAA modulator developed by Concert with the therapeutic potential of treating spasticity and pain in multiple sclerosis (MS). Fast Forward will commit funding to support the program for prospective clinical stage development. We are pleased to partner with Concert on this new approach with the potential to treat spasticity and pain, which are so challenging to large numbers of people living with MS, said Dr. Timothy Coetzee, Chief Research Officer at the National MS Society and Fast Forward. This collaboration demonstrates Fast Forwards commitment to pursue and fund innovative medicines that can address unmet needs and improve the quality of life for people living with this disease. This collaboration with Fast Forward enables us to accelerate development of C-21191 and will provide our team with valuable insight into the management of symptoms associated with multiple sclerosis, said Roger Tung, Ph.D., President and CEO of Concert Pharmaceuticals. It further validates our novel deuterated chemical entity platform as … Continue reading →

Comments Off on Concert Pharmaceuticals and Fast Forward Announce Collaboration to Advance Novel Treatment for Spasticity and Pain in …

1/5 Dead Doctors Don’t Lie Program Genetic Diseases – Video

Posted: Published on March 6th, 2012

05-03-2012 16:57 Dead Doctors Don't Lie Program 02 March 2012 Monologue Dr. Wallach starts the show discussing genetic diseases. Contending that most diseases that have been deemed "genetic" such as Lou Gehrigs disease, Alzheirmer's, Type 2 diabetes and arthritis. Asserting these are due to nutritional deficiencies either in the child or in the mother during conception. Pearls of Wisdom Doug Winfrey and Dr. Wallach discuss two news articles concerning anti-depressant drugs. A study conducted by a Harvard psychologist an Irving Kirsch who has researched the "placebo effects" for over 30 years. Using data he obtained through the Freedom of Information Act has concluded that anti-depressant drug clinical trials showed no proof of efficacy. Finding that several trials showed no efficacy and a small amount showed some efficacy. Only these trials were submitted to the FDA and were ultimately approved for the market. Irving Kirsch has concluded those showing some efficacy were due to the placebo effect. Calls * Bruce has questions regarding joint pain. * JP asks questions concerning hypertension, high cholesterol and ED (erectile dysfunction). * Ray has frequent urination and sinusitis. * Greg has two questions the first concerns his father who has neuropathies in his legs and … Continue reading →

Comments Off on 1/5 Dead Doctors Don’t Lie Program Genetic Diseases – Video

2/5 Dead Doctors Don’t Lie Program – Genetic Diseases – Video

Posted: Published on March 6th, 2012

05-03-2012 18:04 Dead Doctors Don't Lie Program 02 March 2012 Monologue Dr. Wallach starts the show discussing genetic diseases. Contending that most diseases that have been deemed "genetic" such as Lou Gehrigs disease, Alzheirmer's, Type 2 diabetes and arthritis. Asserting these are due to nutritional deficiencies either in the child or in the mother during conception. Pearls of Wisdom Doug Winfrey and Dr. Wallach discuss two news articles concerning anti-depressant drugs. A study conducted by a Harvard psychologist an Irving Kirsch who has researched the "placebo effects" for over 30 years. Using data he obtained through the Freedom of Information Act has concluded that anti-depressant drug clinical trials showed no proof of efficacy. Finding that several trials showed no efficacy and a small amount showed some efficacy. Only these trials were submitted to the FDA and were ultimately approved for the market. Irving Kirsch has concluded those showing some efficacy were due to the placebo effect. Calls * Bruce has questions regarding joint pain. * JP asks questions concerning hypertension, high cholesterol and ED (erectile dysfunction). * Ray has frequent urination and sinusitis. * Greg has two questions the first concerns his father who has neuropathies in his legs and … Continue reading →

Comments Off on 2/5 Dead Doctors Don’t Lie Program – Genetic Diseases – Video

Bad Environment Augments Genetic Risk for Drug Abuse

Posted: Published on March 6th, 2012

News Directors: Broadcast access to VCU experts can be arranged through the universitys VideoLink ReadyCam studio. ReadyCam transmits video and audio via fiber optics through a system that is routed to your newsroom. To schedule a live or taped interview, contact the VCU Office of Communications and Public Relations, (804) 828-1231. Newswise RICHMOND, Va. (March 5, 2012) The risk of abusing drugs is greater even for adopted children if the family environment in which they are raised is dysfunctional, according to a new study conducted by a collaborative team from Virginia Commonwealth University and Lund University in Sweden. Previous research suggests that drug abuse is strongly influenced by a mix of genetic factors and the environment, including influences of family and peers. That research is primarily based on twin studies and typically involves families that are intact. Relatives that share genes and environment make it difficult to determine if the family dysfunction is linked to the drug abuse or if it is genetics at play. There have been no large-scale adoption studies performed to verify the findings, until now. In the study, published online March 5 in the journal Archives of General Psychiatry, researchers examined how genetic and environmental factors … Continue reading →

Comments Off on Bad Environment Augments Genetic Risk for Drug Abuse

VCU study: Bad environment augments genetic risk for drug abuse

Posted: Published on March 6th, 2012

Public release date: 5-Mar-2012 [ | E-mail | Share ] Contact: Sathya Achia Abraham sbachia@vcu.edu 804-827-0890 Virginia Commonwealth University RICHMOND, Va. (March 5, 2012) The risk of abusing drugs is greater even for adopted children if the family environment in which they are raised is dysfunctional, according to a new study conducted by a collaborative team from Virginia Commonwealth University and Lund University in Sweden. Previous research suggests that drug abuse is strongly influenced by a mix of genetic factors and the environment, including influences of family and peers. That research is primarily based on twin studies and typically involves families that are intact. Relatives that share genes and environment make it difficult to determine if the family dysfunction is linked to the drug abuse or if it is genetics at play. There have been no large-scale adoption studies performed to verify the findings, until now. In the study, published online March 5 in the journal Archives of General Psychiatry, researchers examined how genetic and environmental factors contribute to the risk for drug abuse in adoptees. Using a large and representative adoption sample from Sweden, they demonstrate that genetic factors played a moderate role in the liability to drug abuse. … Continue reading →

Comments Off on VCU study: Bad environment augments genetic risk for drug abuse

Page 7,050«..1020..7,0497,0507,0517,052..7,0607,070..»